Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Pharmacology and Experimental Therapeutics
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Journal of Pharmacology and Experimental Therapeutics

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit jpet on Facebook
  • Follow jpet on Twitter
  • Follow jpet on LinkedIn
Research ArticleMetabolism, Transport, and Pharmacogenomics

Sphingolipid Signaling Reduces Basal P-Glycoprotein Activity in Renal Proximal Tubule

David S. Miller
Journal of Pharmacology and Experimental Therapeutics March 2014, 348 (3) 459-464; DOI: https://doi.org/10.1124/jpet.113.210641
David S. Miller
Laboratory of Toxicology and Pharmacology, National Institute of Environmental Health Sciences, National Institutes of Health, Research Triangle Park, North Carolina; and Mount Desert Island Biological Laboratory, Salsbury Cove, Maine
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Article Information

vol. 348 no. 3 459-464
DOI 
https://doi.org/10.1124/jpet.113.210641
PubMed 
24385389

Published By 
American Society for Pharmacology and Experimental Therapeutics
Print ISSN 
0022-3565
Online ISSN 
1521-0103
History 
  • Received October 22, 2013
  • Accepted December 30, 2013
  • Published online January 27, 2014.

Article Versions

  • Earlier version (January 2, 2014 - 10:42).
  • You are viewing the most recent version of this article.
Copyright & Usage 
U.S. Government work not protected by U.S. copyright

Author Information

  1. David S. Miller
  1. Laboratory of Toxicology and Pharmacology, National Institute of Environmental Health Sciences, National Institutes of Health, Research Triangle Park, North Carolina; and Mount Desert Island Biological Laboratory, Salsbury Cove, Maine
  1. Address correspondence to:
    Dr. David S. Miller, Laboratory of Toxicology and Pharmacology, NIH/NIEHS, Research Triangle Park, NC 27709. E-mail: miller{at}niehs.nih.gov
View Full Text

Statistics from Altmetric.com

Article usage

Article usage: January 2014 to May 2022

AbstractFullPdf
Jan 20142681775
Feb 20143821129
Mar 2014141922
Apr 2014701016
May 2014281014
Jun 201431611
Jul 20142896
Aug 20142346
Sep 20142712
Oct 20141111
Nov 20142045
Dec 20142027
Jan 20151533
Feb 20151224
Mar 20152867
Apr 20151637
May 20151969
Jun 2015755
Jul 20151345
Aug 20151195
Sep 20151498
Oct 201520106
Nov 20151758
Dec 201515112
Jan 20161525
Feb 2016922
Mar 201611611
Apr 20167610
May 2016711
Jun 20162589
Jul 20161656
Aug 201621103
Sep 20161267
Oct 20165111
Nov 20169212
Dec 20160136
Jan 20170234
Feb 20172152
Mar 20170213
Apr 20170262
May 20172244
Jun 20171172
Jul 20170110
Aug 20171100
Sep 2017094
Oct 2017181
Nov 2017180
Dec 20172128
Jan 2018341
Feb 20181157
Mar 2018097
Apr 20180123
May 20180153
Jun 20180101
Jul 20180120
Aug 20180113
Sep 2018086
Oct 2018062
Nov 2018073
Dec 2018051
Jan 2019181
Feb 2019925
Mar 2019600
Apr 20192101
May 2019612
Jun 2019304
Jul 2019701
Aug 20191002
Sep 2019912
Oct 20191200
Nov 20191422
Dec 2019271
Jan 2020212
Feb 2020800
Mar 20201111
Apr 20201900
May 2020700
Jun 2020400
Jul 20201710
Aug 2020301
Sep 2020501
Oct 20201600
Nov 2020801
Dec 2020710
Jan 2021923
Feb 20211253
Mar 20211421
Apr 2021920
May 20211152
Jun 2021943
Jul 2021622
Aug 2021643
Sep 2021920
Oct 20211110
Nov 20211522
Dec 20211610
Jan 20222047
Feb 20221013
Mar 2022210
Apr 20221246
May 20221621

PreviousNext
Back to top

In this issue

Journal of Pharmacology and Experimental Therapeutics: 348 (3)
Journal of Pharmacology and Experimental Therapeutics
Vol. 348, Issue 3
1 Mar 2014
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Editorial Board (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Journal of Pharmacology and Experimental Therapeutics article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Sphingolipid Signaling Reduces Basal P-Glycoprotein Activity in Renal Proximal Tubule
(Your Name) has forwarded a page to you from Journal of Pharmacology and Experimental Therapeutics
(Your Name) thought you would be interested in this article in Journal of Pharmacology and Experimental Therapeutics.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleMetabolism, Transport, and Pharmacogenomics

Sphingolipid Signaling in Renal Proximal Tubule

David S. Miller
Journal of Pharmacology and Experimental Therapeutics March 1, 2014, 348 (3) 459-464; DOI: https://doi.org/10.1124/jpet.113.210641

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Research ArticleMetabolism, Transport, and Pharmacogenomics

Sphingolipid Signaling in Renal Proximal Tubule

David S. Miller
Journal of Pharmacology and Experimental Therapeutics March 1, 2014, 348 (3) 459-464; DOI: https://doi.org/10.1124/jpet.113.210641
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Introduction
    • Materials and Methods
    • Results
    • Discussion
    • Acknowledgments
    • Authorship Contributions
    • Footnotes
    • Abbreviations
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • HDL Mimetic 4F Modulates Aβ Distribution in Brain and Plasma
  • AOX1 Inhibition by Gefitinib, Erlotinib, and Metabolites
  • Catalytic Activity of CYP2C9 Variants
Show more Metabolism, Transport, and Pharmacogenomics

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About JPET
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0103 (Online)

Copyright © 2022 by the American Society for Pharmacology and Experimental Therapeutics